Background: Identifying distinct mechanisms and biomarkers for painful diabetic peripheral neuropathy (DPN) is required for advancing the treatment of this major global unmet clinical need. We ...

As many as 3.2 million people in the UK are prediabetic according to Diabetes UK; that is, they are at risk of developing Type 2 diabetes (T2D) due to higher than normal blood glucose levels.

Ruud Dobber, Executive Vice-President, BioPharmaceuticals Business Unit, AstraZeneca, said: “Due to the progressive nature of polyneuropathy of hereditary transthyretin-mediated amyloidosis, it is ...

Rybelsus is an oral form of semaglutide, the active ingredient in the company’s blockbuster Ozempic and Wegovy diabetes and weight-loss drugs, and was tested in the trial on diabetic patients ...

The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, China Objective: To evaluate the prevalence and risk factors of painful diabetic peripheral ...